Scholars Central

Review articlePublished 2018

Amiodarone Use in Pre-Heart Transplant Patients and its Effect on Graft Function and Mortality

Authors: Roy Lee, Kent Nilsson, Amin Yehya

Cardiovascular Pharmacology: Open Access

Volume 7 · Issue 4 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Amiodarone is a commonly used agent to treat life-threatening cardiac arrhythmias in patients with heart failure. While survival after heart transplantation has improved greatly over the decades, the use of amiodarone prior to transplant is controversial. Some reports describe graft dysfunction and increased risk of mortality post-transplant in patients that are exposed to amiodarone pre-operatively, while others do not. Here, we review and summarize the available literature on this topic.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCardiovascular Pharmacology: Open Access
  • SubjectPharmaceutical Sciences
  • SubjectCardiology
  • BylineArticles whose byline prints “Roy Lee”
  • BylineArticles whose byline prints “Kent Nilsson”
  • BylineArticles whose byline prints “Amin Yehya”